STRESS-INDUCED CYCLICAL HYPREPROLACTINEMIA by Jagadheesan, K. et al.
Indian Journal of Psychiatry, 2000, 42 (3), 317-319 
STRESS-INDUCED CYCLICAL HYPREPROLACTINEMIA 
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ABSTRACT 
Both hyperprolactinemia and depressive disorder are known manifestations of hypothyroidism. 
However, hyperprolactinemia with overt symptomatology per se has not been reported to precede 
all episodes of organic depressive disorder. We report a similar presentation. 
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Hyperprolactinemia in women manifests 
as galactorrhoea, menstrual irregularities, 
reduced libido, and other bodily changes 
(Molitch,1995). Hypothyroidism, which causes 
various psychiatric manifestations including 
depressive disorder (Lishman, 1998), is a cause 
for hyperprolactinemia (Molitch,1995). 
Nevertheless, a presentation in which typical and 
recurring features of hyperprolactinemia 
preceded all episodes of depression, following 
stressful life events in a hypothyroid patient, is 
not mentioned in the literature. 
CASE REPORT 
A 38-year-old woman, well adjusted 
premorbidly, having history of manic episode in 
a paternal cousin presented with following 
history. Her problems appeared for the first time, 
six years ago, following a severe quarrel 
with her husband. Within few days, she observed 
whitish discharge from her breasts 
i and decreased sexual desire. This was followed 
five to six days later by insomnia, irritability, 
marked sadness, loss of interest, delusion 
of infidelity, increased religiosity and second 
person auditory hallucinations. However, a 
month later, all these symptoms disappeared 
spontaneously. After an interval of four years, 
following a severe physical illness in her son, 
she had second episode for four weeks with 
similar presentation that resolved again 
spontaneously. 
Third episode with similar picture occurred 
following another stress of similar nature, a year 
later. Presence of marked depressive symptoms 
and a suicidal attempt that followed mammary 
discharge warranted first psychiatric 
consultation. She was prescribed dothiepin 75 
mg/day, haloperidol 0.25 mg/day and alprazolam 
0.5 mg/day. A hormonal assay was ordered 
following history of menorrhagia and weight gain 
for two years. She was found to be hypothyroid 
(T, 3.2 (ug/dl, normal value 5-11.7 (ug/dl; TSH 
5.1 (uu/ml, normal value 0.4-3.8(uu/ml) and 
hyperprolactinemic (serum prolactin 50.6 ng/ml, 
normal maximum value 27.7 ng/ml). Thyroid 
supplementation (thyroxin 0.1 mg/day) resulted 
in complete clinical recovery within a month and 
her hormonal values (Ji 9.82 (ug/dl, TSH 1.12 
(ug/dl, prolactin 16 5ng/ml) returned to normalcy. 
Subsequently, alprazolam, dothiepin and 
haloperidol were stopped but thyroid supplement 
continued. 
However, after an interval of three months, 
she presented to Central Institute of 
Psychiatry (CIP) OPD with her fourth episode 
with similar symptomatology of seven days 
duration, which occurred following her son's brief-
lasting but serious physical illness. Detailed 
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history and psychiatric examination 
revealed mammary discharge preceding lack of 
interest, low mood, easy fatigability, insomnia, 
poor appetite, persecutory delusion and 
auditory and visual hallucinations. Other 
than hoarseness, neurological examination was 
unremarkable. She was provisionally diagnosed 
as a case of organic depressive disorder 
(ICD-10, World Health Organization, 1992). 
Her MRI brain was unremarkable, started 
on risperidone 2-mg/day and fluoxetine 
20-mg/day along with ongoing thyroxin 
supplementation. A month later, she recovered 
completely. 
DISCUSSION 
In this patient, the diagnosis of 
hypothyroidism was based on both clinical and 
laboratory evidences. Though her 
hyperprolactinemia was evidence-based but it 
was mainly diagnosed on clinical grounds. She 
was on psychotropic medication with 
hyperprolactinemic potential (Molitch,1995), 
nonetheless it was unlikely to be drug-induced 
since galactorrhoea preceded all episodes 
spontaneously and psychotropic medicines was 
given only during the third episode. Even during 
this episode, mammary discharge began before 
the depressive syndrome set in. Secondly, apart 
from hypothyroidism, she had no other condition 
that might result in hyperprolactinemia. Hence, 
hypothyroidism was presumed as the most 
probable cause for hyperprolactinemia. 
An important clinical problem, in this 
patient, has been determining the cause for 
depressive episodes, whether it is due to 
hypothyroidism, hyperprolactinemia or stress, 
either alone or in combination. Although anxiety, 
depression and hostility can occur in 
hyperprolactinemic states (Ksllner et al.,1984), 
nothing is clear about the role of prolacin in 
causing discrete psychiatric syndromes (Funente 
&Rosenbaum,1981). Hence, hyperprolactinemia 
may not offer a comprehensive explanation for 
severe depressive episodes. Similarly, 
hypothyroidism was treated and reached 
normalcy and hence, it may not explain 
subsequent clinical decompensation, which 
occurred inspite of continued thyroid supplement, 
In this case, it would be more logical to consider 
the role of stress that is known to inhibit thyroid 
releasing and stimulating hormones, and 
increase prolactin level (Ganong,1995; Molitch, 
1995). Stress, might have been etiologically 
significant in causing hypothyroid state, recurrent 
depression and cyclical hyperprolactinemia. 
Similarly, improvement in both clinical 
hyperprolactinemia and depression could be the 
consequence of disappearance of stress, which 
is evidenced by the spontaneous recovery noted 
in her first two episodes. 
In summary, this report illustrates a clinical 
problem, which may arise while managing 
patients with endocrinological abnormalities. 
Additionally, it also highlights the significance of 
stress in precipitating clinical illness in 
susceptible individuals. This report suggests that 
clinicians handling patients with endocrinological 
abnormalities should look for evidence of stress 
if a well-settled patient relapses acutely without 
an appropriate reason. In addition to 
medications, stress reduction strategies would 
be more helpful in reducing subsequent relapses 
and recurrences. 
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